Medicine

Citing recent data from the CDC, officials in the Garden State will use all of their outreach strategies to promote boosters.

NPR has obtained the government's $5.3 million contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

The move could open the way for the very youngest Americans to start receiving shots by early March.

Defendants present their case in PA's landmark school funding lawsuit. And, a Delaware bill giving terminally ill residents the right to medical aid in dying gains momentum.

People who get infected with omicron are less likely to go to the hospital, go on a ventilator or die. But hospitals are still struggling to treat the huge volume of patients.

It's a sibling of the first omicron variant that swept the world. Is it more contagious? Does it cause severe disease? Will it keep current omicron surges going? Researchers a

The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.

With the Children’s Hospital of Philadelphia’s Center City location often 90% full, the new hospital in Montco is expected to add capacity as demand for beds increases.

COVID-19 vaccine makers have been updating their shots to better match omicron in case global health authorities decide the change is needed.

The FDA said it was revoking emergency authorization for the drugs from Regeneron and Eli Lilly because they don't work against the omicron variant.

City health officials announced earlier this year they had given out more than 260,000 booster doses since August. This is how the numbers break down.

Omicron’s resistance to the two leading monoclonal antibody medicines has upended the treatment playbook for COVID-19 in recent weeks.

The new oral meds are in short supply around Philly, but doctors aren’t prescribing what’s available. Timing and risks are part of the equation.